Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma (REDUCE-30)

NCT07497607 is registered in ClinicalTrials.gov with Sara Medek as lead sponsor.

NCT NCT07497607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07497607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma (REDUCE-30)
Lead sponsor
Sara Medek
Phase
Phase 2
Overall status
Recruiting
Start date
May 13, 2026
Completion date
May 13, 2036
Enrollment
31 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hpv positive oropharyngeal squamous cell carcinoma, oropharyngeal squamous cell carcinoma